Issued Patents All Time
Showing 1–25 of 65 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 12215108 | Development of potential antidotes for arsenicals | Bini Mathew, Corinne E. Augelli-Szafran, Marina Fosso Yatchang, Mohammad Athar, Anupam Agarwal +3 more | 2025-02-04 |
| 12208112 | Composition for treating blood cancer using 4′-thio-5-Aza-2′-deoxycytidine and uses thereof | Rebecca Boohaker, Doo Young Jung, Jin Soo Lee, Hyunyong Cho | 2025-01-28 |
| 12098216 | Modulators of programmed death-ligand-1 and/or programmed death-ligand-2 | Bini Mathew, Rebecca Boohaker | 2024-09-24 |
| 11945781 | Compounds for the treatment of acute and chronic kidney disease | Bini Mathew, Anupam Agarwal, Amie M. Traylor | 2024-04-02 |
| 11905258 | 2-aminoaryl-5-aryloxazole analogs for the treatment of neurodegenerative diseases | Bini Mathew, Rita Cowell, Corinne E. Augelli-Szafran | 2024-02-20 |
| 11753374 | Compounds for the treatment of acute and chronic kidney disease | Bini Mathew, Anupam Agarwal, Amie M. Traylor | 2023-09-12 |
| 11752153 | Substituted quinazoline sulfonamides as thioredoxin interacting protein (TXNIP) inhibitors | Corinne E. Augelli-Szafran, Omar Moukha-Chafiq, Anath Shalev, Lance Thielen, Junqin Chen +1 more | 2023-09-12 |
| 11718593 | 2,5-aryl-thiazole analogs for the treatment of neurodegenerative diseases | Bini Mathew, Rita Cowell, Corinne E. Augelli-Szafran | 2023-08-08 |
| 11623918 | Compounds for the treatment of acute and chronic kidney disease | Bini Mathew, Anupam Agarwal, Amie M. Traylor | 2023-04-11 |
| 11524010 | Substituted quinazoline sulfonamides as thioredoxin interacting protein (TXNIP) inhibitors | Corinne E. Augelli-Szafran, Omar Moukha-Chafiq, Anath Shalev, Lance Thielen, Junqin Chen +1 more | 2022-12-13 |
| 11505531 | Piperazine-2,5-diones as TGF-beta inhibitors | Vandana Gupta, Wei Zhang, Joanne Murphy-Ullrich | 2022-11-22 |
| 11472781 | 2-aminoaryl-5-aryloxazole analogs for the treatment of neurodegenerative diseases | Bini Mathew, Rita Cowell, Corinne E. Augelli-Szafran | 2022-10-18 |
| 11447472 | Polymorophs of 5-aza-4′-thio-2′-deoxycytidine | Doo Young Jung, Jin Soo Lee, Hyunyong Cho | 2022-09-20 |
| 11103508 | Substituted quinazoline sulfonamides as thioredoxin interacting protein (TXNIP) inhibitors | Corinne E. Augelli-Szafran, Omar Moukha-Chafiq, Anath Shalev, Lance Thielen, Junqin Chen +1 more | 2021-08-31 |
| 11066357 | Benzoannulene derivatives as antiviral agents | Ashish Kumar Pathak, Syed Kaleem Ahmed, Corinne E. Augelli-Szafran | 2021-07-20 |
| 11046729 | Dipeptide analogs as TGF-beta inhibitors | Vandana Gupta, Bini Mathew, Joanne Murphy-Ullrich | 2021-06-29 |
| 11033535 | Oxadiazoles and thiadiazoles as TGF-β inhibitors | Vandana Gupta, Bini Mathew, Joanne Murphy-Ullrich | 2021-06-15 |
| 10653682 | Oxadiazoles and thiadiazoles as TGF-β inhibitors | Vandana Gupta, Bini Mathew, Joanne Murphy-Ullrich | 2020-05-19 |
| 10294235 | Pyrrolopyrimidine compounds, use as inhibitors of the kinase LRRK2, and methods for preparation thereof | Corinne E. Augelli-Szafran, Robert A. Galemmo, Jr., Omar Moukha-Chafiq, Vandana Gupta, Subramaniam Ananthan | 2019-05-21 |
| 10023579 | Pyrrolopyrimidine compounds, use as inhibitors of the kinase LRRK2, and methods for preparation thereof | Corinne E. Augelli-Szafran, Robert A. Galemmo, Jr., Omar Moukha-Chafiq, Vandana Gupta, Subramaniam Ananthan | 2018-07-17 |
| 9375419 | Antiviral agents | — | 2016-06-28 |
| 9353149 | Compounds, compositions and methods for the treatment of diseases through inhibiting TGF-β activity | Joanne Murphy-Ullrich | 2016-05-31 |
| 9018208 | Heterocycles as potassium channel modulators | Thomas Eugene Christos, George S. Amato, Robert N. Atkinson, Maria Graciela Barolli, Lilli Ann Wolf-Gouveia | 2015-04-28 |
| 8927587 | Chemical compounds | Sharanjeet Kaur Bagal, Alan Daniel Brown, Mark Ian Kemp, Wolfgang Klute, Laia Malet Sanz +4 more | 2015-01-06 |
| 8853250 | Sodium channel inhibitors | Serge Beaudoin, Matthew Scott Johnson, Brain Edward Marron | 2014-10-07 |